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Abstract
■ The development and expression of the midbrain dopamine
system is determined in part by genetic factors that vary across
individuals such that dopamine-related genes are partly respon-
sible for addiction vulnerability. However, a complete account
of how dopamine-related genes predispose individuals to drug
addiction remains to be developed. Adopting an intermediate
phenotype approach, we investigated whether reward-related
electrophysiological activity of ACC—a cortical region said to
utilize dopamine reward signals to learn the value of extended,
context-specific sequences of goal-directed behaviors—mediates
the influence of multiple dopamine-related functional poly-
morphisms over substance use. We used structural equation
modeling to examine whether two related electrophysiological
phenomena associated with the control and reinforcement learn-
ing functions of ACC—theta power and the reward positivity—
mediated the relationship between the degree of substance mis-
use and genetic polymorphisms that regulate dopamine pro-
cessing in frontal cortex. Substance use data were collected
from 812 undergraduate students. One hundred ninety-six re-
turned on a subsequent day to participate in an electrophysio-
logical experiment and to provide saliva samples for DNA
analysis. We found that these electrophysiological signals medi-
ated a relationship between the DRD4-521T dopamine receptor
genotype and substance misuse. Our results provide a theoretical
framework that bridges the gap between genes and behavior
in drug addiction and illustrate how future interventions might
be individually tailored for specific genetic and neurocognitive
profiles. ■
INTRODUCTION
Despite the fact that substance use disorders are partly
heritable (Johnson et al., 2008; Uhl et al., 2008), compel-
ling evidence linking individual genes with the disorders
remains elusive. One strategy for addressing complex
gene–disease relationships depends on the concept of
intermediate phenotypes (IPs): biological and psycholog-
ical factors that are relatively proximal to genetic influence
and confer vulnerability to (rather than determine) psy-
chopathology (Meyer-Lindenberg & Weinberger, 2006).
It has been suggested that IPs should be defined in
relation to the cardinal features of a disorder such as a
subclinical variant of a form of major psychopathology1
(Lenzenweger, 2013; Loth, Carvalho, & Schumann,
2011; Meyer-Lindenberg & Weinberger, 2006). In the
case of substance misuse, the consumption of drugs and
alcohol is considered problematic when it imposes a sig-
nificant cost on the individual, is difficult to interrupt, is
likely to recur after interruption, and continues despite
long-term adverse consequences (Lima et al., 2015)—
characteristics that are strongly suggestive of impaired
cognitive control2 (Hyman, Malenka, & Nestler, 2006). This
behavioral profile therefore suggests the identification of
IPs that relate to the expression of flexible and adaptive
goal-directed behaviors in this population.
In this study, we utilize the cognitive control function
of ACC as an IP that elucidates the genetic contribution
to substance misuse. Although the specific role of ACC in
control is highly controversial, a recent theory holds that
ACC motivates the execution of extended, goal-directed
sequences of behavior according to principles of hierar-
chical reinforcement learning (Holroyd & McClure, 2015;
Holroyd & Yeung, 2012), a process that is said to be facil-
itated by the impact of dopamine reward prediction error
signals on ACC (RPE-ACC theory; Holroyd & Coles, 2002).
RPEs constitute the learning term in powerful reinforce-
ment learning algorithms that indicate when events are
“better” or “worse” than expected (Sutton & Barto,
1998). Current thinking holds that positive and negative
RPEs are encoded as phasic increases and decreases in
the firing rate of midbrain dopamine neurons, respec-
tively (Schultz, 2010, 2011, 2013). The RPE-ACC theory
extends this concept by proposing that ACC utilizes neg-
ative and positive RPEs to learn the value of extended,
context-specific sequences of behavior directed toward
particular goals (Holroyd & Yeung, 2012).
ACC is also strongly implicated in addiction (Peoples,
2002), but its contribution to this disorder is still rela-
tively unknown. Extensive empirical and theoretical work1University of Victoria, 2University of Montreal
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has shown that addictive drugs potentiate dopaminergic
RPE signals (Schultz, 2011; Redish, Jensen, & Johnson,
2008; Redish, 2004) by raising extracellular dopamine
levels either directly or indirectly (Di Chiara & Bassareo,
2007; Rice & Cragg, 2004; Di Chiara & Imperato, 1988).
Although much attention has focused on the impact of
aberrant dopaminergic signaling on the function of the
striatum (Volkow, Wang, Fowler, & Tomasi, 2012; Volkow,
Wang, Fowler, Tomasi, & Telang, 2011), a region com-
monly thought to learn and implement relatively simple
stimulus–response associations (Yin & Knowlton, 2006),
this altered processing likely extends to ACC, an important
neural target of the dopamine system (Gaspar, Berger,
Febvret, Vigny, & Henry, 1989). In the context of the
RPE-ACC theoretical framework, we have argued that the
distortion of RPE signals by addictive drugs would upset
the normal function of ACC, biasing the action selection
mechanism to favor extended behaviors that ultimately
converge on drug use (Baker, 2012; Baker, Stockwell,
Barnes, & Holroyd, 2011).
Several genetic studies have also implicated dopamine
and ACC in cognitive control and addiction. In particular,
functional polymorphisms of the DRD4 gene, which
plays a fundamental role in the overall inhibitory modu-
lation of frontal cortex neuronal activity (Onn, Wang, Lin,
& Grace, 2006; Rubinstein et al., 2001), and the catechol-
O-methyltransferase (COMT) gene, which plays a crucial
role in the metabolism of dopamine in frontal cortex
(Chen et al., 2004), modulate cognitive control functions
related to ACC (Marco-Pallares et al., 2009; Kramer et al.,
2007). For example, DRD4 functional polymorphisms—
namely, the promoter −521 C/T (rs1800955) and the
Indel−1217G ins/del (−/G) (rs12720364) single-nucleotide
genetic polymorphisms (SNPs) of the DRD4 gene (Oak,
Oldenhof, & Van Tol, 2000)—are associated with ACC func-
tion (Fan, Fossella, Sommer, Wu, & Posner, 2003; Oak
et al., 2000) and appear to modulate electrophysiolog-
ical markers of feedback processing (Agam et al., 2014;
Manoach & Agam, 2013; Marco-Pallares et al., 2010; Marco-
Pallares et al., 2009). Furthermore, the val158met (rs4680)
SNP of the COMT gene, which accounts for a fourfold
decrease in catabolism of dopamine and other catechol-
amines in frontal cortex (Chen et al., 2004), has been linked
to cognitive flexibility and working memory functions re-
lated to frontal cortex (Dickinson & Elvevag, 2009). Impor-
tantly, functional polymorphisms of the DRD4 and COMT
gene have also been implicated in addiction, including
alcohol craving, and alcohol, nicotine, opioid, and canna-
bis misuse (McGeary, 2009; Ray et al., 2009; Baransel Isir
et al., 2008; Oosterhuis et al., 2008; Mackillop, Menges,
McGeary, & Lisman, 2007; Beuten, Payne, Ma, & Li, 2006;
Hutchison, McGeary, Smolen, Bryan, & Swift, 2002; Oak
et al., 2000).
Neuroimaging-based measures have emerged as par-
ticularly promising candidates for assessing IPs because
they reveal neurocognitive processes that can be altered
in clinical disorders (Rasetti & Weinberger, 2011). Here,
we utilize two related electrophysiological signals asso-
ciated with ACC function—theta power and the reward
positivity (RP)—to serve as indices of our proposed ACC-
related IP. Both of these phenomena have been exten-
sively studied in parallel, decade-long literatures. With
regard to the former signal, EEG oscillations in the theta
frequency range (4–8 Hz) recorded over frontal midline
areas of the scalp have, since the 1970s, been associated
with cognitive process related to effort, attention, and
motivation (for reviews, see Hsieh & Ranganath, 2014;
Mitchell, McNaughton, Flanagan, & Kirk, 2008). Further-
more, unexpected, task-relevant events elicit a brief burst
of power in the theta frequency range about 200–300 msec
after the event that appears to index the deployment of
control (Cavanagh & Frank, 2014; Cavanagh, Zambrano-
Vazquez, & Allen, 2012). With respect to the latter signal,
the RP is observed as a differential response in the ERP
to positive and negative feedback stimuli, occurring over
frontal–central areas of the scalp about 250–300 msec after
feedback (Miltner, Braun, & Coles, 1997). The RPE-ACC
theory holds that the RP is produced by the impact of
phasic increases and decreases in dopamine activity cod-
ing for positive and negative RPEs, respectively, on ACC
(Holroyd, Pakzad-Vaezi, & Krigolson, 2008; Holroyd &
Coles, 2002). Substantial evidence over the past decade
has confirmed that the RP reflects an RPE signal (for re-
views, see Sambrook & Goslin, 2015; Walsh & Anderson,
2012).
Furthermore, converging evidence across multiple
methodologies indicates that ACC is the source of both
frontal midline theta oscillations (Holroyd, 2015) and the
RP (Holroyd & Yeung, 2012). The fact that feedback-
induced theta power and the RP occur at about the same
time (200–300 msec after feedback) and share the same
scalp location (over the frontal midline) suggests a func-
tional relationship between these two phenomena. In
particular, recent examinations of the RP and theta power
have provided a nuanced account about their relation-
ship (Hajihosseini & Holroyd, 2013). On this account,
unexpected, task-relevant events elicit an ACC-dependent
control process that manifests in the frequency domain
as theta oscillations over frontal–central areas of the scalp
(Cavanagh & Frank, 2014). In the time domain, the
“evoked” portion of this theta activity that is consistent
in phase across trials gives rise to an ERP component
called the N200 (Hajihosseini & Holroyd, 2013; see also
Yeung, Bogacz, Holroyd, & Cohen, 2004). This account
holds that both theta and the N200 constitute a baseline
response to unexpected events and, furthermore, that
N200 amplitude is regulated up and down by dopamine
RPE signals conveyed to ACC. Thus, positive dopamine
RPE signals conveyed to ACC about 300 msec after un-
expected positive feedback (Zaghloul et al., 2009) sup-
presses the production of the N200 (Holroyd, Krigolson,
& Lee, 2011; Holroyd et al., 2008; see Proudfit, 2015, for a
review), whereas negative dopamine RPE signals enhance
N200 amplitude (Warren & Holroyd, 2012). For this reason,
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the RP is typically operationalized as the size of the differ-
ence wave calculated between good (positive RPE) and
bad (negative RPE) outcome ERPs (Sambrook & Goslin,
2015; Holroyd & Krigolson, 2007; Miltner et al., 1997).
In view of the close relationship between these phe-
nomena, we included both theta and the RP as a com-
bined index of our proposed ACC-related IP. Note that
the amplitude of the RP is heritable and has excellent
test–retest reliability, indicating that the RP provides a
stable, trait-like neural measure (Weinberg & Hajcak,
2011; Olvet & Hajcak, 2008) or a susceptibility-related
phenotype (Proudfit, 2015) of the underlying reward
process. Furthermore, we have previously reported that
the RP was attenuated in undergraduate students meeting
criteria for substance dependence, which is suggestive of
disrupted dopamine RPE signaling in this population
(Baker et al., 2011). In fact, numerous studies have shown
the RP to be abnormal in several psychiatric disorders
(Proudfit, 2015), consistent with the idea that ACCmay im-
plement a crucial neurocognitive function that cuts across
traditional diagnostic categories (Holroyd & Umemoto,
2015; see also Cuthbert & Insel, 2013; Insel et al., 2010).
We propose that ACC’s putative function—selecting
and motivating the execution of goal-directed extended
sequences of actions based on reinforcement learning
principles—can be utilized as an IP for the abnormal
cognitive control processes underlying individual differ-
ences in substance misuse. In particular, we propose that
SNPs that regulate the expression of dopamine processes
in frontal cortex (i.e., DRD4, COMT) may contribute
to the degree of substance misuse observed in under-
graduate students by modulating ACC activity as revealed
in individual differences in RP amplitude and theta
power. To test this idea, we measured the RP and theta
power from first- and second-year undergraduate
students while they navigated a virtual T-maze by trial-
and-error to find rewards as in our previous study (Baker
et al., 2011). All participants were screened for prob-
lematic substance use and provided saliva samples for
DNA analysis. Importantly, we applied structural equation
modeling (SEM) to examine whether theta power and
RP amplitude would show an intermediate relationship
between several dopamine-related genetic polymorphisms
(i.e., the promoter −521 [rs1800955] and indel −1217G
[rs12720364] SNP of theDRD4 gene and val158met polymor-
phism [rs4680] of the COMT gene) and the degree of sub-
stance misuse in undergraduate students. The IP approach
constitutes a natural application of SEM, which provides
a means for modeling such complex interrelationships.
METHODS
Participants
In keeping with a previous experiment (Baker et al.,
2011), we collected questionnaire data from 812 under-
graduate students recruited from the University of Victoria,
each of whom received course credit in a psychology
course for their participation. Participants were allowed
60 min to complete the questionnaire in a computer labo-
ratory at the University of Victoria, and up to 20 participants
completed the questionnaire at a time. They were pro-
vided with both written and verbal instructions that
explained the procedure and were instructed that they
should answer each of the questions truthfully and to the
best of their knowledge. The computer-based question-
naire was composed of several separate inventories that
assess problematic drug use, the degree of addiction vul-
nerability, and personality risk factors for substance depen-
dence. At the end of the questionnaire, participants were
asked whether they would like to return on a subsequent
day to participate in an electrophysiological and behavioral
experiment and to provide saliva samples for DNA analysis
(Table 1). Of these 812 participants, 196 agreed to partici-
pate in the subsequent experiment; this proportion of
returning participants (24%) was comparable with that
of our previous study (17%; Baker et al., 2011). The data
of one participant were excluded because of a con-
taminated DNA sample. All remaining participants had
normal or corrected-to-normal vision, and all participants
gave informed consent. The study was approved by the
local research ethics committee and was conducted in
accordance with the ethical standards prescribed in the
1964 Declaration of Helsinki.
For the purpose of this study, we defined the level of
substance misuse as frequency of substance use behav-
iors that impose a significant cost on the individual, are
difficult to interrupt, and are likely to recur after inter-
ruption. Substance misuse by this definition was measured
as a continuous variable using the Global Continuum of
Substance Risk (GCR) score of the World Health Organi-
zation Alcohol, Smoking and Substance Involvement
Screening Test (ASSIST; Humeniuk et al., 2008). The
ASSIST is a validated screening test using DSM-specific cri-
teria for identifying the degree of problematic substance use
Table 1. Genotype Characteristics of the Research Sample
Population
Genetic Characteristics (n = 195)
Gene SNP SNP rs# Allele/Phenotype/Sample
DRD4 C-521T 1800955 CC ↑↑ CT ↑↓ TT ↓↓
n = 43 n = 107 n = 45
– Indel 12720364 GG −G −/−a
n = 75 n = 89 n = 29
COMT Val158Met 4680 MM ↓↓ MV ↑↓ VV ↑↑
n = 54 n = 101 n = 40
↑↓ denotes an increase or decrease in dopaminergic phenotype.
aPhenotype currently unknown.
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(i.e., tobacco, alcohol, cannabis, cocaine, amphetamine-type
stimulants, sedatives, hallucinogens, inhalants, opioids, and
“other drugs”), especially in individuals who consume a
variety of different substances with varying degrees of use,
for example, as occurs with polydrug use. Usages of indi-
vidual substances were each scored according to the
ASSIST guidelines (Humeniuk et al., 2008), and scores
were combined to derive the GCR score. To be specific,
the GCR score was based on the sum of response weights
to Questions 1–8 (1. Have you ever used Substance A?
2. Used in the past 3 months? 3. During the past 3 months,
how often have you had a strong desire or urge to use
this substance? 4. During the past 3 months, how often
has your use of this substance led to health, social, legal,
or financial problems? 5. During the past 3 months, how
often have you failed to do what was normally expected of
you because of your use of this substance? 6. Has a friend
or relative or anyone else EVER expressed concern about
your use of this substance? 7. Have you ever tried and
failed to control, cut down, or stop using this substance?
8. Have you ever used any drug by injection?) across the
following drug classes: tobacco, alcohol, cannabis, cocaine,
amphetamine-type stimulants, sedatives, hallucinogens,
inhalants, opioids and “other drugs.”
Importantly, the ASSIST allows for generalization of
results across substance-dependent (SD) populations
and is less dependent on the distribution of any given
sample (Humeniuk et al., 2008). As reported in a vali-
dation study by Newcombe, Humeniuk, and Ali (2005),
the significant correlation between the GCR score and
the score derived from the Severity of Dependence Scale
suggests that the GCR score is a valid measure of severity
of dependence for the individual concerned. Following
the screening procedure utilized in our previous study
of substance dependence (Baker et al., 2011), personal-
ity risk factors for substance dependence were also
assessed, but these factors were not the focus of this
investigation and are discussed elsewhere (Baker,
Stockwell, & Holroyd, 2013). All information obtained
was kept strictly confidential and stored in a locked filing
cabinet.
Genotyping
Purified DNA was obtained from participants by collect-
ing and processing saliva samples using Oragene OG-
500 DNA Collection Kits (DNA Genotek, Ottawa, Canada)
as per the manufacturer’s instructions. Each participant’s
sample was processed at the Center for Biomedical
Research DNA Sequencing Facility, University of Victoria.
Several separate regions of genomic DNA, each con-
taining a polymorphism of interest, were amplified by
polymerase chain reaction and purified. Genotyping of
the DRD4 C-521T and DRD4 −127 Indel SNPs was ac-
complished by digestion with a restriction endonuclease
appropriate to each polymorphism and subsequent sep-
aration by agarose gel electrophoresis. Genotyping of
the COMT Val156Met polymorphisms was accomplished
by tetra-primer amplification refractory mutation system-
polymerase chain reaction and subsequent separation by
agarose gel electrophoresis. Each genotyping method for
each SNP target was verified by performing DNA sequence
analysis (LI-COR 4200 Genetic Analyzer, Lincoln, NE) on a
representative subset of samples. Genotyping of SNPs
(DRD2 Taqα1, PPP1R1B rs879606, PPP1R1B rs907094,
DRD2 C957T, and DRD2 rs12364283) related to behavioral
performance on a decision-making task (Frank, Seeberger,
O’Reilly, 2004) was also performed, the results of which
are reported elsewhere (Baker et al., 2013; Baker, 2012).
Electrophysiological Task: Virtual T-Maze
The virtual T-maze is a reward-based choice task that
elicits robust RPs (Baker et al., 2011; Baker & Holroyd,
2009). At the start of each block of trials, participants
were shown three different aerial views of the maze, each
for 3 sec, to familiarize themselves with its virtual dimen-
sions (Figure 1, top row). On each trial, participants were
presented with an image of the base arm of a T-maze
showing the length of the arm and two alleys projecting
to the left and to the right from its far end (Figure 1, bot-
tom). Participants were instructed to choose one of the
two arms by pressing either a left or right button. Then,
they were shown a view of the alley that they selected,
followed by an image of either an apple or an orange
appearing against the far wall of that alley. Participants
were told that presentation of one type of fruit indicated
that the alley they selected contained 5 cents (Reward
feedback) and that the presentation of the other fruit
indicated that the alley they selected was empty (No-
reward feedback); the mappings between feedback
stimuli and reward types were counterbalanced across
participants. Participants were also informed that, at the
Figure 1. The virtual T-maze task. (Top) Three views of T-maze from
above. (Bottom) Sequence of events constituting an example trial of the
T-maze task; stimulus durations are indicated at the bottom of each
panel. The double arrow remained visible until the button press. Please
note that the size of the arrow was magnified in this figure for the
purpose of exposition.
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end of the experiment, they would be rewarded all the
money they found and that they were to respond in a
way that maximized the total amount of money earned.
Unbeknownst to them, on each trial, the type of feedback
stimulus was selected at random (50% probability for each
feedback type, which is a standard probability used to elicit
a robust RP). The experiment consisted of four blocks of
100 trials each separated by rest periods. Upon completing
the T-maze, participants engaged in a decision-making
task (Frank et al., 2004), the results of which are reported
elsewhere (Baker et al., 2013). At the end of the experi-
ment, participants were informed about the probabilities
and were given a $10 performance bonus.
Data Acquisition
EEG was recorded using a montage of 36 electrodes
placed according to the extended international 10–20
system (Jasper, 1958). Signals were acquired using Ag–
AgCl ring electrodes mounted in a nylon electrode cap
with a conductive gel (Falk Minow Services, Herrsching,
Germany). Signals were amplified by low-noise electrode
differential amplifiers with a frequency response of DC
0.017–67.5 Hz (90-dB octave roll-off ) and digitized at a
rate of 250 samples per second. Digitized signals were
recorded to disk using Brain Vision Recorder software
(Brain Products GmbH, Munich, Germany). Electrode
impedances were maintained below 10 kΩ. Two elec-
trodes were also placed on the left and right mastoids.
The EEG was recorded using the average reference. For
the purpose of artifact correction, the horizontal EOG
was recorded from the external canthi of both eyes,
and vertical EOG was recorded from the suborbit of
the right eye and electrode channel Fp2.
Data Analysis
Postprocessing and data visualization were performed
using Brain Vision Analyzer software (Brain Products
GmbH). The digitized signals were filtered using a
fourth-order digital Butterworth filter with a bandpass
of 10–20 Hz. An 800-msec epoch of data extending from
200 msec before to 600 msec after the onset of each
feedback stimulus was extracted from the continuous
data file for analysis. Ocular artifacts were corrected using
the eye movement correction algorithm described by
Gratton, Coles, and Donchin (1983). The EEG data were
rereferenced to linked mastoids electrodes. The data
were baseline-corrected by subtracting from each sample
the mean voltage associated with that electrode during
the 200-msec interval preceding stimulus onset. Muscular
and other artifacts were removed using a ±150-μV level
threshold and a ±35-μV step threshold as rejection cri-
teria. ERPs were then created for each electrode and
participant by averaging the single-trial EEG according
to feedback type (Reward, No-reward).
Reward Positivity
RP amplitude is typically assessed as the size of the differ-
ence in the ERPs elicited to positive and negative feed-
back stimuli of equal expectancy (Sambrook & Goslin,
2015; Holroyd & Krigolson, 2007). Thus, to isolate the
RP from other overlapping ERP components, the RP
was evaluated for each electrode channel and participant
as a difference wave by subtracting the Reward feedback
ERPs from the corresponding No-reward feedback ERPs
(Sambrook & Goslin, 2015; Holroyd & Krigolson, 2007;
Miltner et al., 1997). The size of the RP was then deter-
mined by identifying the peak amplitude of the differ-
ence between the Reward and No-reward ERPs within a
200- to 400-msec window after feedback onset. For statis-
tical analysis, the RP was measured at channel FCz, where
it reaches maximum amplitude (Holroyd & Krigolson,
2007; Miltner et al., 1997).
Theta Power
Theta power was obtained by computing a single-trial
wavelet-based time–frequency analysis using custom-
written MATLAB routines that implement the method de-
scribed by Lachaux, Rodriguez, Martinerie, and Varela
(1999). The continuous EEG data were segmented in
5000-msec epochs (2500 msec preceding to 2500 msec
after feedback presentation) and filtered using a fourth-
order digital Butterworth filter with a bandpass from 0.1
to 40 Hz. Single-trial EEG data were convoluted with a
complex seven-cycle Morlet wavelet in the frequencies
of interest (from 1 to 40 Hz; linear increase in steps of
2 Hz) averaged for each participant before performing
a grand average. The relative change in the power for
each condition was determined by averaging the baseline
activity (100-msec prestimulus: −300 to −200 msec)
across time for each frequency and then subtracting the
average from each data point after stimulus presentation
for the corresponding frequency (for a complete de-
scription of the analysis procedure, see Hajihosseini &
Holroyd, 2013). Each epoch was then separated into
epochs extending from −500 to +1000 msec after stim-
ulus onset. For each participant, we calculated the mean
power for theta (4–8 Hz) within a temporal window
extending across this interval, and the peak power and
latency were obtained by detecting power maximum
within a 600-msec window after the onset of the feedback
stimulus. This analysis was restricted to channel FCz
where frontal-midline theta is maximal (Cavanagh &
Shackman, 2015; Hajihosseini & Holroyd, 2013).
Statistical Analysis
Data analysis was performed using SPSS 17.0.1 forWindows
(SPSS, Inc., Chicago, IL), and the SEM was tested and mod-
ified using the computer program AMOS 18.0.1 (Arbuckle,
1995–2009). Descriptive statistics were obtained to
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characterize the sample (Table 1). SEM is a confirmatory
modeling technique for theory development and testing.
Confirmatory modeling entails operationalizing a hy-
pothesis in a causal model to test specific interrelationships
between elements of the hypothesis. Here, we examined
whether our theoretically constrained IP model (in which
the relationships between genes and IP measures were
“fixed” based on observations from previous studies)
could adequately account for the contribution of several
dopamine-related genes to substance dependence. In
particular, we examined whether theta power and RP
amplitude could account for the contribution of DRD4
C-521T, DRD4 −127 Indel SNPs, and COMT Val156Met
polymorphisms to substance misuse as defined by the
GCR score (the degree of problematic substance use).
To be specific, GCR scores were included in this model
as the outcome measure, with the RP (evaluated as the
size of the difference wave taken between Reward and
No-reward ERPs) and total theta power (θ) elicited by
feedback during the virtual T-maze task as first-order pre-
dictor variables (Figure 2). Furthermore, given the hypoth-
esis that phasic dopamine signals modulate the amplitude
of ACC-generated theta oscillations to produce the RP
(Hajihosseini & Holroyd, 2013), we allowed theta power
to predict the amplitude of the RP in the proposed model
(Figure 2). The paths between the functional polymor-
phisms and the IP were based on their previous associa-
tions with frontal cortical function.
The ACC-IP model was tested and modified (if needed)
using the computer program AMOS 18.0.1 (Arbuckle,
1995–2009), which estimated the error terms of the di-
rectly observable variables that were assumed to be uncor-
related with each other. We examined the indirect effects
in the model using a bootstrapping method (1000 times;
Shrout & Bolger, 2002; Bollen & Stine, 1990). Model per-
formance was assessed with various fit criteria, including
the chi-square test, comparative fit index (CFI; Bentler,
1990), goodness-of-fit test (GFI; Tabachnick & Fidell,
2007), and the root mean square error of approximation
(RMSEA; Browne & Cudeck, 1993). The CFI and the
RMSEA are sensitive to model misspecification and are
minimally affected by sample size (Hu & Bentler, 1995).
The CFI ranges from 0 to 1, with .90 indicating accept-
able fit (Bentler, 1990). RMSEA fit values less than .05 indi-
cate close fit, and values less than .10 indicate reasonable
fit (Steiger, 1990). The GFI explains what proportion of the
variance/covariance patterns in the sample variance is
accounted for by the model matrix; GFI values should
exceed .9 for a “reasonable” model and .95 for an “impres-
sive” model (Tabachnick & Fidell, 2007).
In the case where model fit was poor, we performed
post hoc model modifications using the modification in-
dices (MIs) provided by the AMOS program to identify
better-fitting models (Schumacker & Lomax, 2004). An
MI represents the expected decrease of the chi-square
statistic if that pair of variables were allowed to covary
in the model. Thus, variables exhibiting high MIs likely
contribute to multicollinearity and as such are good
candidates for creating a covariance path between them,
which can improve the model fit without affecting the
model’s theoretical interpretation (Hooper, Coughlan,
& Mullen, 2008). The post hoc modifications were based
on empirically and theoretically sound criteria, as de-
scribed below. To maintain a family-wise Type 1 error
rate of 5%, we modified only model variables with MIs
greater than 12.83 (Tabachnick & Fidell, 2007).
RESULTS
Participants
Participants (147 women, 48 men) were 20.4 (SD = 4.1,
range = 18–51) years old on average (Table 2), and 91%
of the sample was white. Although the sample was pre-
dominantly female, comparable to our first study (Baker
et al., 2011), no gender differences were observed be-
tween RP amplitude, t(193), 1.3, p > .1, or theta power,
t(193), 0.99, p > .1), indicating that gender was not a
confounding factor. Genotype groups did not differ with
regard to gender, age, or ethnicity ( p> .05); therefore, it
is unlikely that the following analyses were confounded
by population stratification. Furthermore, our sample
showed no deviation from Hardy–Weinberg equilibrium
(Rodriguez, Gaunt, & Day, 2009) expectations at any of
the selected loci for the overall sample ( p > .05), indi-
cating that the observed genotype frequencies are consis-
tent with previous studies of primarily white, unselected
samples. Behavioral measures for the T-maze task can be
found in the supplementary online material (SOM).
SEM
Figure 2 depicts the SEM results. The GFIs indicated
that the hypothesized IP model provided a very strong
Figure 2. SEM results. Paths constituting statistically significant indirect
effects are highlighted in orange. Nonsignificant paths are shown as
dashed lines. Significant standardized regression coefficients for
direct effects are provided along paths (*p < .05, ***p < .001), and
explained variances are provided (r2). Full model results are provided
in Table S1–S4. θ = theta power; GCR = GCR score of the World
Health Organization ASSIST (Humeniuk et al., 2008). The model
includes the DRD4 C-521T, DRD4 −127 Indel SNPs, and COMT
Val156Met polymorphisms.
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fit to the GCR scores as per conventional criteria (χ2 =
4.74, df = 6, p = .577, CFI = .99, GFI = .99, RMSEA <
.001, 90% CI [<0.001, 0.07], χ2/df ratio = .80), explaining
approximately 8% of individual variance in GCR. No model
modifications were necessary. Critically, the RP strongly
predicted participants’ GCR score (beta = .27, p < .001),
indicating that, as RP amplitude decreased, the level of
problematic substance use increased; Figure 3 illustrates
the reduction in RP amplitude when participants were
grouped categorically according to levels of drug misuse,
replicating a previous finding (Baker et al., 2011; see also
SOM). Note that visual inspection of the raw ERP wave-
forms to Reward and No-reward feedback for SD and
nondependent (ND) individuals indicates that this dif-
ference is driven in the SD group by a reduced positive
deflection to rewards, replicating findings from our pre-
vious addiction study (Baker et al., 2011). Critically, in
both studies, the negative deflections to No-reward feed-
back were virtually identical between SD and ND groups,
confirming that the effect of interest was isolated to the
predicted ERP component, the RP.
In turn, theta power contributed significantly to the
amplitude of the RP (beta = −.28, p < .001), consistent
with previous observations (Hajihosseini & Holroyd,
2013). Although the genotypes together did not reliably
predict RP amplitude, the model revealed that the pro-
moter C-521T polymorphism of the DRD4 gene uniquely
predicted theta power (beta = −.16, p < .05), indicating
that an increase in C alleles (increase in D4) predicted
less theta power (Figure 4, bottom), consistent with pre-
vious findings (Marco-Pallares et al., 2009). Furthermore,
the relationship between theta power and DRD4-521
Table 2. Demographic Characteristics of the Research Sample Population
Sample Characteristics (n = 196)
Median Mean Standard Deviation
Range
Min Max
Age 19.0 20.1 4.3 18 51
GCR (max: 208) 24.0 28.3 21.0 1 104
Validation studya 23.0 27.3 19.6 1 141
RP (μV) −5.10 −4.71 3.54 −20.93 1.64
Total theta power (dB) 0.61 0.70 0.43 −0.63 2.26
aHumeniuk et al. (2008), n = 1047.
Figure 3. Grand-averaged ERPs
associated with Reward (blue
dotted lines) and No-reward
(red dashed lines) outcomes
and RP (black solid lines). For
the purpose of illustration, the
ERPs of participants with GCR
scores falling within the bottom
quartile (solid lines, n = 58;
GCR score < 16, labeled ND)
and top quartile (dashed lines,
n = 43; GCR score > 41,
labeled SD) are presented
(see also SOM). These scores
are comparable to the cutoffs
established in previous
validation studies of the ASSIST
for nondependence (score <
15) and dependence (score >
39.5; Humeniuk et al., 2008)
as well as our previous study
(Baker et al., 2011). Negative
voltages are plotted up by
convention. (Top right) Scalp
voltage maps associated with
the peak value of the difference
waves for ND (left) and SD
(right) grand averages.
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expression was strikingly similar across Reward and No-
reward conditions (theta Reward, F(2, 192) = 2.89, p <
.05; theta No-reward, F(2, 192) = 2.89, p < .05), indicat-
ing that individuals carrying the T allele expressed more
theta power than did individuals carrying the C allele,
irrespective of the condition. Thus, the D4 receptor ap-
pears to play a general, nonspecific inhibitory role in
pFC. Finally, the indirect effect from the DRD4 C-521T
genotype to the RP through theta was statistically signifi-
cant ( p = .012), and the indirect effect from theta power
to GCR score through the RP was statistically significant
( p = .002), indicating that the variation in DRD4-521
gene can influence the level of substance dependence
indirectly through the degree of engagement of ACC.3
DISCUSSION
We applied SEM to investigate whether two electrophys-
iological phenomena related to the cognitive control
function of ACC (RP amplitude and theta power) can
serve as an IP for substance misuse. Our model results
point to a specific molecular pathway by which the
DRD4-521 genotype alters ACC electrophysiology and
thereby predicts the level of problematic substance
use in undergraduate students. To be specific, the RP
(Warren, Hyman, Seamans, & Holroyd, 2015; Proudfit,
2015; Emeric et al., 2008) and frontal midline theta oscil-
lations (Cavanagh & Frank, 2014) are believed to be pro-
duced within caudal ACC. A detailed examination of
these phenomena has indicated that theta power reflects
a “default” response by ACC to unexpected task-relevant
events (Holroyd, Larsen, & Cohen, 2004) and that the RP
is produced by dopamine-dependent RPE signals to un-
expected rewarding outcomes that suppress the default
response (Hajihosseini & Holroyd, 2013). Furthermore,
a recent theory holds that ACC uses dopamine reward
signals for learning the value of extended, context-specific
sequences of behavior directed toward particular goals
(Holroyd & Yeung, 2012). Evaluated in this context, our
findings of reduced RP amplitude in individuals who tend
to misuse drugs of abuse suggest abnormal goal-directed
behavior in this population (Baker, 2012; Baker et al.,
2011).
Furthermore, the fact that these electrophysiological
phenotypes were selectively modulated by a DRD4-related
genetic polymorphism specifically implicates ACC D4 re-
ceptors in addiction. D4 receptors are highly expressed
in frontal regions for cognitive control including ACC and
pFC (Mulcrone & Kerwin, 1997), where their activation by
tonic dopamine inhibits neural firing (Onn et al., 2006;
Rubinstein et al., 2001). These receptors appear partly
responsible for regulating behavioral shifts between dif-
ferent task strategies (Floresco & Magyar, 2006; see also
Holroyd & McClure, 2015). For example, high levels of
D4 activity in rodents can impair performance on goal-
orientated set-shifting tasks (by increasing the commission
of perseverative errors), whereas less D4 activity can lead
to an improvement, suggesting that D4 receptor activation
may antagonize phasic activity underlying behavioral flexi-
bility (Floresco & Magyar, 2006). Consistent with this
evidence, human electrophysiological studies have shown
that the T allele of the promoter −521 (C/T) SNP
(rs1800955) of the DRD4 gene, which is associated with
40% less transcriptional efficiency of D4 receptors (Okuyama,
Ishiguro, Toru, & Arinami, 1999; but see Kereszturi et al.,
Figure 4. Time–frequency
analysis of the EEG associated
with outcome processing.
Panel indicates changes in
power for each frequency band
by condition (top left: Reward,
top right: No-reward, bottom
left: total power) with respect
to baseline. (Bottom right)
DRD4 C-521T gene dose effect
on theta power. Individuals
with more T alleles displayed
relatively more theta power
after feedback onset. EEG
data recorded at channel
FCz.
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2006), impacts frontal cortex functioning related to cog-
nitive control (Kramer et al., 2007).
In this study, we found that C allele carriers associated
with enhanced D4 expression (Okuyama et al., 1999; but
see Kereszturi et al., 2006) of the DRD4 promoter −521
SNP displayed a relatively suppressed theta response
by medial frontal cortex to salient or unexpected task-
relevant events. In turn, there was an indirect effect of
theta on GCR score through the RP. In line with the hier-
archical reinforcement learning theory of ACC (Holroyd &
McClure, 2015; Holroyd & Yeung, 2012), this indirect
pathway suggests that D4 receptors may play a pivotal
role in decision-making over extended behaviors, a
process that goes awry in substance use disorders. We
speculate that, whereas too many D4 receptors would
suppress the normal reinforcement learning function of
ACC, the dopamine-potentiating effects of addictive
substances would compound this problem, resulting in
unstable reward valuation as revealed by our electro-
physiological measures. Conversely, decreased D4 expres-
sion could promote optimal ACC function by enabling it
to respond dynamically to reinforcement signals such as
by switching to a new behavioral state. This function is
suggested by the relatively strong theta response of medial
frontal cortex to salient events, which evidently reflects
the release of ACC from tonic dopamine-induced inhibi-
tion. According to this account, a genotype associated
with stronger cognitive control may act as a protective
mechanism against the dopamine-potentiating effects of
addictive substances.
This study raises several issues related to the relation-
ship between dopamine-related SNPs and electrophysio-
logical effects related to cognitive control. First, whereas
previous studies have reported links between ERPs re-
lated to performance monitoring (response-locked error-
related negativity, feedback error-related negativity) and
dopamine-related genes (i.e., DRD4, COMT; for a review,
see Manoach & Agam, 2013; see also Agam et al., 2014),
in this study, none of the genotypes significantly predicted
RP amplitude. Most candidate gene investigations have
analyzed condition-specific ERPs related to error-locked
ERP averages (e.g., error-related negativity, feedback-error
related negativity), whereas here we quantified the size
of the RP using a subtraction method, which could have
contributed to this inconsistency across studies. Further-
more, because the data averaging process underlying the
ERP approach can obscure oscillatory signals that vary in
phase across trials (Tallon-Baudry & Bertrand, 1999), our
results suggest that time–frequency analysis (which is
less sensitive to such latency variability) might better reveal
D4-dependent electrophysiological effects related to cog-
nitive control. Second, previous studies have focused on
candidate genes (DRD4, COMT) that are implicated in
general processes related to cognitive control (e.g., error
processing; Marco-Pallares et al., 2009; Kramer et al.,
2007) but not necessarily related to reward processing
per se. Our theoretical framework suggests that the RP
may be more closely linked to genes that are associated
with the proposed reward function of ACC (e.g., the
DRD1 SNP [rs686]; e.g., Baker et al., 2015). Relatedly, the
relationship between DRD-521 SNP and D4 expression is
still debated, in part because the gene is highly polymor-
phic (Kereszturi et al., 2006). Future studies could investi-
gate other polymorphisms of the DRD4 promoter region in
the context of different genetic haplotypes, such as the
SNPs in positions −768, −616, −615, −603, and −600,
which may also influence promoter activity (Kereszturi
et al., 2006).
A limitation of the study is that the sample consisted of
undergraduate students recruited from the University of
Victoria who may not be representative of the population
in general nor of severely dependent substance users in
particular. However, nearly a quarter of the sample met
the ASSIST criteria for substance dependence. Further-
more, the mean GCR score for this SD group (61) ap-
proached the mean GCR score of individuals who
completed several weeks of treatment for substance de-
pendence (83; Baker et al., 2013), indicating that this
subgroup expressed elevated levels of problematic use
of addictive substances. For this reason, we believe that
this undergraduate population provides a reasonable
point of departure for examining substance misuse in
other populations. Note also that the GCR score of the
WHO ASSIST identifies individuals who tend to abuse
multiple substances rather than individuals who present
a pure clinical case. Given the high prevalence of poly-
substance abuse in young adults between the ages of
18 and 24 years (Barrett, Darredeau, & Pihl, 2006) and
that individuals who abuse only a single addictive drug
comprise only a small segment of the general population,
we believe that this operational definition of substance
misuse is appropriate. Our study thus reveals that indi-
viduals who abuse multiple substances share important
neural abnormalities in reward processing and cognitive
control irrespective of their particular drugs of choice.
These results can be investigated further in future studies
that expand the sample to include other populations of
users who abuse particular drugs or drug types (such as
stimulants vs. sedatives).
In summary, our results suggest that genetically deter-
mined overexpression of D4 receptors in medial frontal
cortex disrupts the association of extended, goal-directed
behaviors with positive value (Holroyd & McClure, 2015;
Holroyd & Yeung, 2012), conferring vulnerability to the
potentiating effects of addictive drugs. These findings
motivate further study of the role of cognitive control
in mediating the impact of dopamine-related genetic
polymorphisms on psychopathology and suggest how
future interventions could be individually tailored for
specific genetic and neurocognitive profiles. For instance,
we speculate that excessive dopaminergic inhibition of
frontal cortex, particularly in individuals who carry the C
allele of the DRD4-521 SNP, might be alleviated by admin-
istration of pharmaceuticals (such as D4 antagonists)
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or neuromodulation techniques (such as TMS; e.g., Baker
et al., 2015), in addition to application of cognitive–
behavioral therapy to develop better coping strategies.
By identifying how the brain links genes to addiction,
novel treatments and early diagnosis for substance use
disorders may finally be on the horizon.
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Notes
1. Rasetti and Weinberger (2011) state, “To link a gene effect
in brain to the gene effect on risk for the syndromal diagnosis, it
is necessary to show that the brain effect is a biological sub-
strate also linked to risk, a so-called intermediate phenotype”
(p. 340).
2. Cognitive control, broadly defined, refers to a collection of
cognitive processes related to the regulation of thought, emo-
tion, and actions in the service of achieving current and future
goals (i.e., goal-directed behavior; Miller & Cohen, 2001).
3. Because of recent controversy about the construct validity
of the RP with respect to frontal midline theta oscillations
(Hajihosseini & Holroyd, 2013; Holroyd, Hajihosseini, & Baker,
2012; Cohen, Wilmes, & van de Vijver, 2011), we also analyzed
competing models and compared the results against our pro-
posed model. These alternative models included a model that
excluded the RP IP, a model that included theta power sepa-
rately for Reward and No-reward feedback (while excluding
the RP), and a model that included paths between genes and
GCR. Overall, model comparisons indicated that our hypothe-
sized ACC-IP model provided the best fit to the data when com-
pared with alternative models (see SOM).
REFERENCES
Agam, Y., Vangel, M., Roffman, J. L., Gallagher, P. J., Chaponis,
J., Haddad, S., et al. (2014). Dissociable genetic contributions
to error processing: A multimodal neuroimaging study. PLoS
ONE, 9, e101784.
Arbuckle, J. L. (1995–2009). Amos 18 user’s guide. Chicago, IL:
SPSS.
Baker, T. E. (2012). Genetics, drugs, and cognitive control:
Uncovering individual differences in substance
dependence. PhD dissertation, Brain and Cognitive Science,
University of Victoria.
Baker, T. E., & Holroyd, C. B. (2009). Which way do I go? Neural
activation in response to feedback and spatial processing in a
virtual T-maze. Cerebral Cortex, 19, 1708–1722.
Baker, T. E., Stockwell, T., Barnes, G., & Holroyd, C. B. (2011).
Individual differences in substance dependence: At the
intersection of brain, behaviour and cognition. Addiction
Biology, 16, 458–466.
Baker, T. E., Stockwell, T., & Holroyd, C. B. (2013). Constraints
on decision making: Implications from genetics, personality,
and addiction. Cognitive, Affective & Behavioral
Neuroscience, 13, 417–436.
Baker, T. E., Tucholka, A., Potvin, S., Lesperance, P., Jutras-
Aswad, D., Larcher, K., et al. (2015). Optimizing combined
fMRI-DTI-TMS-ERP methods to identify and regulate reward
valuation during nicotine craving. Poster presented at the
21st Annual Meeting of the Organization for Human Brain
Mapping, Honolulu, HI.
Baransel Isir, A. B., Oguzkan, S., Nacak, M., Gorucu, S., Dulger,
H. E., & Arslan, A. (2008). The catechol-O-methyl transferase
Val158Met polymorphism and susceptibility to cannabis
dependence. American Journal of Forensic Medicine and
Pathology, 29, 320–322.
Barrett, S. P., Darredeau, C., & Pihl, R. O. (2006). Patterns of
simultaneous polysubstance use in drug using university
students. Human Psychopharmacology: Clinical and
Experimental, 21, 255–263.
Bentler, P. M. (1990). Comparative fit indices in structural
models. Psychological Bulletin, 107, 238–246.
Beuten, J., Payne, T. J., Ma, J. Z., & Li, M. D. (2006).
Significant association of catechol-O-methyltransferase
(COMT) haplotypes with nicotine dependence in male
and female smokers of two ethnic populations.
Neuropsychopharmacology, 31, 675–684.
Bollen, K. A., & Stine, R. A. (1990). Direct and indirect effects:
Classical and bootstrap estimates of variability. Sociological
Methodology, 20, 115–140.
Browne, M. W., & Cudeck, R. (1993). Alternative ways of
assessing model fit. In K. Bollen & K. Long (Eds.)
pp. 136–162.
Cavanagh, J. F., & Frank, M. J. (2014). Frontal theta as a
mechanism for cognitive control. Trends in Cognitive
Sciences, 18, 414–421.
Cavanagh, J. F., & Shackman, A. J. (2015). Frontal midline theta
reflects anxiety and cognitive control: Meta-analytic evidence.
Journal of Physiology, Paris, 109, 3–15.
Cavanagh, J. F., Zambrano-Vazquez, L., & Allen, J. J. (2012).
Theta lingua franca: A common mid-frontal substrate for
action monitoring processes. Psychophysiology, 49, 220–238.
Chen, J., Lipska, B. K., Halim, N., Ma, Q. D., Matsumoto, M.,
Melhem, S., et al. (2004). Functional analysis of genetic
variation in catechol-O-methyltransferase (COMT): Effects
on mRNA, protein, and enzyme activity in postmortem
human brain. American Journal of Human Genetics, 75,
807–821.
Cohen, M. X., Wilmes, K. & van de Vijverl, I. (2011). Cortical
electrophysiological network dynamics of feedback learning.
Trends in Cognitive Sciences, 15, 558–566.
Cuthbert, B. N., & Insel, T. R. (2013). Toward the future of
psychiatric diagnosis: The seven pillars of RDoC. BMC
Medicine, 11, 126.
Di Chiara, G., & Bassareo, V. (2007). Reward system and
addiction: What dopamine does and doesn’t do. Current
Opinion in Pharmacology, 7, 69–76.
Di Chiara, G., & Imperato, A. (1988). Drugs abused by humans
preferentially increase synaptic dopamine concentrations in
the mesolimbic system of freely moving rats. Proceedings of
the National Academy of Sciences, U.S.A., 85, 5274–5278.
Dickinson, D., & Elvevag, B. (2009). Genes, cognition and brain
through a COMT lens. Neuroscience, 164, 72–87.
Emeric, E. E., Brown, J. W., Leslie, M., Pouget, P., Stuphorn, V.,
& Schall, J. D. (2008). Performance monitoring local field
potentials in the medial frontal cortex of primates: Anterior
cingulate cortex. Journal of Neurophysiology, 99, 759–772.
Baker et al. 469
Fan, J., Fossella, J., Sommer, T., Wu, Y., & Posner, M. I. (2003).
Mapping the genetic variation of executive attention onto
brain activity. Proceedings of the National Academy of
Sciences, U.S.A., 100, 7406–7411.
Floresco, S. B., & Magyar, O. (2006). Mesocortical dopamine
modulation of executive functions: Beyond working memory.
Psychopharmacology, 188, 567–585.
Frank, M. J., Seeberger, L. C., & O’Reilly, R. C. (2004). By carrot
or by stick: Cognitive reinforcement learning in
parkinsonism. Science, 306, 1940–1943.
Gaspar, P., Berger, B., Febvret, A., Vigny, A., & Henry, J. P.
(1989). Catecholamine innervation of the human cerebral
cortex as revealed by comparative immunohistochemistry of
tyrosine hydroxylase and dopamine-beta-hydroxylase.
Journal of Comparative Neurology, 279, 249–271.
Gratton, G., Coles, M. G., & Donchin, E. (1983). A newmethod for
off-line removal of ocular artifact. Electroencephalography
Clinical Neurophysiology, 55, 468–484.
Hajihosseini, A., & Holroyd, C. B. (2013). Frontal midline theta
and N200 amplitude reflect complementary information
about expectancy and outcome evaluation. Psychophysiology,
50, 550–562.
Holroyd, C. B. (2015). The waste disposal problem of effortful
control. In T. Braver (Ed.), Motivation and cognitive control
(pp. 235–260). New York: Psychology Press.
Holroyd, C. B., & Coles, M. G. (2002). The neural basis of
human error processing: Reinforcement learning, dopamine,
and the error-related negativity. Psychological Review,
109, 679–709.
Holroyd, C. B., HajiHosseini, A., & Baker, T. E. (2012). ERPs and
EEG oscillations, best friends forever: Comment on Cohen
et al. Trends in Cognitive Sciences, 16, 192.
Holroyd, C. B., & Krigolson, O. E. (2007). Reward prediction
error signals associated with a modified time estimation task.
Psychophysiology, 44, 913–917.
Holroyd, C. B., Krigolson, O. E., & Lee, S. (2011). Reward
positivity elicited by predictive cues. NeuroReport,
22, 249–252.
Holroyd, C. B., Larsen, J. T. & Cohen, J. D. (2004). Context
dependence of the eventrelated brain potential associated
with reward and punishment. Psychophysiology,
41, 245–253.
Holroyd, C. B., & McClure, S. M. (2015). Hierarchical control
over effortful behavior by rodent medial frontal cortex: A
computational model. Psychological Review, 122, 54–83.
Holroyd, C. B., Pakzad-Vaezi, K. L., & Krigolson, O. E. (2008).
The feedback correct-related positivity: Sensitivity of the
event-related brain potential to unexpected positive
feedback. Psychophysiology, 45, 688–697.
Holroyd, C. B., & Umemoto, A. (2015). Anterior cingulate
function and dysfunction in health and disease. Conference
Abstract-Psychophysiology, 52, S37.
Holroyd, C. B., & Yeung, N. (2012). Motivation of extended
behaviors by anterior cingulate cortex. Trends in Cognitive
Sciences, 16, 122–128.
Hooper, D., Coughlan, J. & Mullen, M. R. (2008). Structural
equation modelling: Guidelines for determining model fit.
Journal of Business Research Methods, 6, 53–60.
Hsieh, L. T., & Ranganath, C. (2014). Frontal midline theta
oscillations during working memory maintenance and
episodic encoding and retrieval. Neuroimage, 85, 721–729.
Humeniuk, R., Ali, R., Babor, T. F., Farrell, M., Formigoni, M. L.,
Jittiwutikarn, J., et al. (2008). Validation of the Alcohol,
Smoking and Substance Involvement Screening Test (ASSIST).
Addiction, 103, 1039–1047.
Hu, L., & Bentler, P. (1995). Evaluating model fit. In R. H. Hoyle
(Ed.), Structural equation modeling: Concepts, issues, and
applications (pp. 76–99). Thousand Oaks, CA: Sage.
Hutchison, K. E., McGeary, J., Smolen, A., Bryan, A., & Swift, R. M.
(2002). The DRD4 VNTR polymorphism moderates craving
after alcohol consumption. Health Psychology, 21, 139–146.
Hyman, S. E., Malenka, R. C., & Nestler, E. J. (2006). Neural
mechanisms of addiction: The role of reward-related learning
and memory. Annual Review of Neuroscience, 29, 565–598.
Insel, T., Cuthbert, B., Garvey, M., Heinssen, R., Pine, D. S.,
Quinn, K., et al. (2010). Research domain criteria (RDoC):
Toward a new classification framework for research on
mental disorders. American Journal of Psychiatry, 167,
748–751.
Jasper, H. H. (1958). The ten twenty electrode system of
the international federation. Electroencephalography and
Clinical Neurophysiology, 10, 371.
Johnson, C., Drgon, T., Liu, Q. R., Zhang, P. W., Walther, D., Li,
C. Y., et al. (2008). Genome wide association for substance
dependence: Convergent results from epidemiologic and
research volunteer samples. BMC Medical Genetics, 9, 113.
Kereszturi, E., Kiraly, O., Barta, C., Molnar, N., Sasvari-Szekely,
M., & Csapo, Z. (2006). No direct effect of the -521 C/T
polymorphism in the human dopamine D4 receptor gene
promoter on transcriptional activity. BMC Molecular Biology,
7, 18.
Kramer, U. M., Cunillera, T., Camara, E., Marco-Pallares, J.,
Cucurell, D., Nager, W., et al. (2007). The impact of catechol-
O-methyltransferase and dopamine D4 receptor genotypes
on neurophysiological markers of performance monitoring.
Journal of Neuroscience, 27, 14190–14198.
Lachaux, J. P., Rodriguez, E., Martinerie, J., & Varela, F. J. (1999).
Measuring phase synchrony in brain signals. Human Brain
Mapping, 8, 94–208.
Lenzenweger, M. F. (2013). Endophenotype, intermediate
phenotype, biomarker: Definitions, concept comparisons,
clarifications. Depression and Anxiety, 30, 185–189.
Lima, D. R., Goncalves, P. D., Malbergier, A., Amaral, R.,
Andrade, A. G., & Cunha, P. J. (2015). The DSM-5 and the
diagnosis of substance use disorders: Reflection about
validity of the new criteria and possible ‘missing pieces’ in
the puzzle. Australian and New Zealand Journal of
Psychiatry, 49, 940–941.
Loth, E., Carvalho, F., & Schumann, G. (2011). The contribution
of imaging genetics to the development of predictive
markers for addictions. Trends in Cognitive Sciences,
15, 436–446.
Mackillop, J., Menges, D. P., McGeary, J. E., & Lisman, S. A.
(2007). Effects of craving and DRD4 VNTR genotype on the
relative value of alcohol: An initial human laboratory study.
Behavioral and Brain Functions, 3, 11.
Manoach, D. S., & Agam, Y. (2013). Neural markers of errors as
endophenotypes in neuropsychiatric disorders. Frontiers in
Human Neuroscience, 7, 350.
Marco-Pallares, J., Cucurell, D., Cunillera, T., Kramer, U. M.,
Camara, E., Nager, W., et al. (2009). Genetic variability
in the dopamine system (dopamine receptor D4,
catechol-O-methyltransferase) modulates neurophysiological
responses to gains and losses. Biological Psychiatry,
66, 154–161.
Marco-Pallarés, J., Nager, W., Krämer, U. M., Cunillera, T.,
Càmara, E., & Cucurell, D. (2010). Neurophysiological
markers of novelty processing are modulated by COMT and
DRD4 genotypes. Neuroimage, 53, 962–969.
McGeary, J. (2009). The DRD4 exon 3 VNTR polymorphism
and addiction-related phenotypes: A review. Pharmacology,
Biochemistry and Behavior, 93, 222–229.
Meyer-Lindenberg, A., & Weinberger, D. R. (2006).
Intermediate phenotypes and genetic mechanisms of
psychiatric disorders. Nature Reviews Neuroscience,
7, 818–827.
470 Journal of Cognitive Neuroscience Volume 28, Number 3
Miller, E. K., & Cohen, J. D. (2001). An integrative theory of
prefrontal cortex function. Annual Review of Neuroscience,
24, 167–202.
Miltner, W. H. R., Braun, C. H., & Coles, M. G. H. (1997). Event-
related brain potentials following incorrect feedback in a
time-estimation task: Evidence for a ‘generic’ neural system
for error detection. Journal of Cognitive Neuroscience, 9,
788–798.
Mitchell, D. J., McNaughton, N., Flanagan, D., & Kirk, I. J. (2008).
Frontal-midline theta from the perspective of hippocampal
“theta”. Progress in Neurobiology, 86, 156–185.
Mulcrone, J., & Kerwin, R. W. (1997). The regional pattern of
D4 gene expression in human brain. Neuroscience Letters,
234, 147–150.
Newcombe, D. A., Humeniuk, R. E., & Ali, R. (2005). Validation
of the World Health Organization Alcohol, Smoking and
Substance Involvement Screening Test (ASSIST): Report of
results from the Australian site. Drug Alcohol Review, 24,
217–217.
Oak, J. N., Oldenhof, J., & Van Tol, H. H. (2000). The dopamine
D(4) receptor: One decade of research. European Journal of
Pharmacology, 405, 303–327.
Okuyama, Y., Ishiguro, H., Toru, M., & Arinami, T. (1999).
A genetic polymorphism in the promoter region of DRD4
associated with expression and schizophrenia. Biochemical
and Biophysical Research Communications, 258, 292–295.
Olvet, D. M., & Hajcak, G. (2008). The error-related negativity
(ERN) and psychopathology: Toward an endophenotype.
Clinical Psychology Review, 28, 1343–1354.
Onn, S. P., Wang, X. B., Lin, M., & Grace, A. A. (2006).
Dopamine D1 and D4 receptor subtypes differentially
modulate recurrent excitatory synapses in prefrontal cortical
pyramidal neurons. Neuropsychopharmacology, 31, 318–338.
Oosterhuis, B. E., LaForge, K. S., Proudnikov, D., Ho, A., Nielsen,
D. A., Gianotti, R., et al. (2008). Catechol-O-methyltransferase
(COMT) gene variants: Possible association of the
Val158Met variant with opiate addiction in Hispanic women.
American Journal of Medical Genetics, Part B:
Neuropsychiatric Genetics, 147B, 793–798.
Peoples, L. L. (2002). Neuroscience. Will, anterior cingulate
cortex, and addiction. Science, 296, 1623–1624.
Proudfit, G. H. (2015). The reward positivity: From basic
research on reward to a biomarker for depression.
Psychophysiology, 52, 449–459.
Rasetti, R., & Weinberger, D. R. (2011). Intermediate
phenotypes in psychiatric disorders. Current Opinion in
Genetics and Development, 21, 340–348.
Ray, L. A., Bryan, A., Mackillop, J., McGeary, J., Hesterberg, K., &
Hutchison, K. E. (2009). The dopamine D receptor (DRD4)
gene exon III polymorphism, problematic alcohol use and
novelty seeking: Direct and mediated genetic effects.
Addiction Biology, 14, 238–244.
Redish, A. D. (2004). Addiction as a computational process
gone awry. Science, 306, 1944–1947.
Redish, A. D., Jensen, S., & Johnson, A. (2008). A unified
framework for addiction: Vulnerabilities in the decision
process. Behavioral and Brain Sciences, 31, 415–437.
Rice, M. E., & Cragg, S. J. (2004). Nicotine amplifies reward-
related dopamine signals in striatum. Nature Neuroscience,
7, 583–584.
Rodriguez, S., Gaunt, T. R., & Day, I. N. (2009). Hardy-Weinberg
equilibrium testing of biological ascertainment for Mendelian
randomization studies. American Journal of Epidemiology,
169, 505–514.
Rubinstein, M., Cepeda, C., Hurst, R. S., Flores-Hernandez, J.,
Ariano, M. A., Falzone, T. L., et al. (2001). Dopamine D4
receptor-deficient mice display cortical hyperexcitability.
Journal of Neuroscience, 21, 3756–3763.
Sambrook, T. D., & Goslin, J. (2015). A neural reward
prediction error revealed by a meta-analysis of ERPs
using great grand averages. Psychological Bulletin, 141,
213–235.
Schultz, W. (2010). Dopamine signals for reward value and risk:
Basic and recent data. Behavioral and Brain Functions,
6, 24.
Schultz, W. (2011). Potential vulnerabilities of neuronal reward,
risk, and decision mechanisms to addictive drugs. Neuron,
69, 603–617.
Schultz, W. (2013). Updating dopamine reward signals. Current
Opinion in Neurobiology, 23, 229–238.
Schumacker, R. E. & Lomax, R. G. (2004). A beginner’s guide to
structural equation modeling (2nd ed.). Mahwah, NJ:
Lawrence Erlbaum.
Shrout, P. E., & Bolger, N. (2002). Mediation in experimental
and nonexperimental studies: New procedures and
recommendations. Psychological Methods, 7, 422–445.
Steiger, J. H. (1990). Structural model evaluation and
modification: An interval estimation approach. Multivariate
Behavioral Research, 25, 173–180.
Sutton, R. S., & Barto, A. G. (1998). Reinforcement learning:
An introduction. IEEE Transactions on Neural Networks,
9, 1054.
Tabachnick, B. G., & Fidell, L. S. (2007). Using Multivariate
Statistics, 5th ed. New York: Allyn and Bacon.
Tallon-Baudry, C. & Bertrand, O. (1999). Oscillatory gamma
activity in humans and its role in object representation.
Trends in Cognitive Sciences, 3, 151–162.
Uhl, G. R., Drgon, T., Johnson, C., Li, C. Y., Contoreggi, C.,
Hess, J., et al. (2008). Molecular genetics of addiction and
related heritable phenotypes: Genome-wide association
approaches identify “connectivity constellation” and drug
target genes with pleiotropic effects. Annals of the New York
Academy of Sciences, 1141, 318–381.
Volkow, N. D., Wang, G. J., Fowler, J. S., & Tomasi, D. (2012).
Addiction circuitry in the human brain. Annual Review of
Pharmacology and Toxicology, 52, 321–336.
Volkow, N. D., Wang, G. J., Fowler, J. S., Tomasi, D., & Telang,
F. (2011). Addiction: Beyond dopamine reward circuitry.
Proceedings of the National Academy of Sciences, U.S.A.,
108, 15037–15042.
Walsh, M. M., & Anderson, J. R. (2012). Learning from
experience: Event-related potential correlates of reward
processing, neural adaptation, and behavioral choice.
Neuroscience & Biobehavioral Reviews, 36, 1870–1884.
Warren, C. M., & Holroyd, C. B. (2012). The impact of
deliberative strategy dissociates ERP components related to
conflict processing vs. reinforcement learning. Frontiers in
Neuroscience, 6, 43.
Warren, C. M., Hyman, J. M., Seamans, J. K., & Holroyd, C. B.
(2015). Feedback-related negativity observed in rodent
anterior cingulate cortex. Journal of Physiology, Paris, 109,
87–94.
Weinberg, A., & Hajcak, G. (2011). Longer term test-retest
reliability of error-related brain activity. Psychophysiology, 48,
1420–1425.
Yeung, N., Bogacz, R., Holroyd, C. B., & Cohen, J. D.
(2004). Detection of synchronized oscillations in the
electroencephalogram: An evaluation of methods.
Psychophysiology, 41, 822–832.
Yin, H. H., & Knowlton, B. J. (2006). The role of the basal
ganglia in habit formation. Nature Reviews Neuroscience, 7,
464–476.
Zaghloul, K. A., Blanco, J. A., Weidemann, C. T., McGill, K.,
Jaggi, J. L., Baltuch, G. H., et al. (2009). Human substantia
nigra neurons encode unexpected financial rewards. Science,
323, 1496–1499.
Baker et al. 471
